MedTrace Logo

Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy

NCT02762929 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 430

Last updated 2026-02-23

Study results available
· View outcomes & findings →

Summary

A Phase 2, Randomized, Controlled, Multicenter, Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy

Conditions

  • Postoperative Pain
  • Bunions

Interventions

DRUG

HTX-011A

HTX-011A (bupivacaine/meloxicam), via injection.

BIOLOGICAL

Saline Placebo

Saline placebo via injection.

DRUG

HTX-011B

HTX-011B (bupivacaine/meloxicam), via injection or instillation.

DRUG

HTX-002

HTX-002, via injection.

DRUG

Bupivacaine HCl

Bupivacaine HCI, via injection.

DRUG

HTX-009

HTX-009, via injection.

Sponsors & Collaborators

  • Heron Therapeutics

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-02-28
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02762929 on ClinicalTrials.gov